-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..: "fremanezumab for the preventive treatment of chronic migraine."..
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�.
every single pronouncement, on any subject, issued via the medical cartel�s ministry of truth would fall on disbelieving ears, and only increase general outrage..